";s:4:"text";s:4722:" The baseline ESS scores for the Modafinil tablets and placebo groups were 14.2 and 14.4, respectively. Results from this clinical study demonstrated that Modafinil produced psychoactive and euphoric effects and feelings consistent with other scheduled CNS stimulants (methylphenidate).In one placebo-controlled clinical trial, the effects of Modafinil withdrawal were monitored following 9 weeks of Modafinil use. Other observed high-dose effects in clinical studies have included anxiety, irritability, aggressiveness, confusion, nervousness, tremor, palpitations, sleep disturbances, nausea, diarrhea, and decreased prothrombin time.From postmarketing experience, there have been reports of fatal overdoses involving modafinil alone or in combination with other drugs. However, in a subsequent study of up to 480 mg/kg/day of Modafinil, no adverse effects on embryofetal development were observed.
The adverse reaction profile was similar across these studies.Table 1 presents the adverse reactions that occurred at a rate of 1% or more and were more frequent in Modafinil tablets-treated patients than in placebo-treated patients in the placebo-controlled clinical trials. Nearly all cases of serious rash associated with Modafinil occurred within 1 to 5 weeks after treatment initiation. In elderly patients, elimination of modafinil and its metabolites may be reduced as a consequence of aging. Modafinil tablets are not approved in this population for any indication.Serious skin rashes, including erythema multiforme major (EMM) and Stevens-Johnson Syndrome (SJS) have been associated with Modafinil use in pediatric patients In a controlled 6-week study, 165 pediatric patients (aged 5 to 17 years) with narcolepsy were treated with Modafinil (n=123), or placebo (n=42). Only two metabolites reach appreciable concentrations in plasma, i.e., modafinil acid and modafinil sulfone. Modafinil tablets, USP are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD).The recommended dosage of Modafinil tablets for patients with narcolepsy or OSA is 200 mg taken orally once a day as a single dose in the morning.Doses up to 400 mg/day, given as a single dose, have been well tolerated, but there is no consistent evidence that this dose confers additional benefit beyond that of the 200 mg/day dose The recommended dosage of Modafinil tablets for patients with SWD is 200 mg taken orally once a day as a single dose approximately 1 hour prior to the start of their work shift.In patients with severe hepatic impairment, the dosage of Modafinil tablets should be reduced to one-half of that recommended for patients with normal hepatic function Consideration should be given to the use of lower doses and close monitoring in geriatric patients 100 mg – White, round, biconvex tablets, engraved "MOD" over "100" on one side, "APO" on the other side.Modafinil tablets are contraindicated in patients with known hypersensitivity to Modafinil or arModafinil or its inactive ingredients Serious rash requiring hospitalization and discontinuation of treatment has been reported in association with the use of Modafinil.In clinical trials of Modafinil, the incidence of rash resulting in discontinuation was approximately 0.8% (13 per 1,585) in pediatric patients (age <17 years); these rashes included 1 case of possible Stevens-Johnson Syndrome (SJS) and 1 case of apparent multi-organ hypersensitivity reaction.
Patients treated with Provigil showed a statistically significantly enhanced ability to remain awake on the MWT at each dose compared to placebo at final visit (Table 2). Modafinil has wake-promoting actions similar to sympathomimetic agents including amphetamine and methylphenidate, although the pharmacologic profile is not identical to that of the sympathomimetic amines.Modafinil-induced wakefulness can be attenuated by the α1-adrenergic receptor antagonist, prazosin; however, Modafinil is inactive in other Modafinil is not a direct- or indirect-acting dopamine receptor agonist. Modafinil is one of those compounds that makes most readers step mexico the moment modafinil zopiclone 5mg hear about it.